FindMyRecallSubscribe
Class II: temporary or reversible health riskTerminated

Ascend Laboratories Metformin Hydrochloride Tablets Recall

Metformin Hydrochloride Tablets, USP 500 mg, 1000 tablets, Rx Only Manufactured by: Al…

Ascend Laboratories LLC · Montvale, NJ

Risk level
Class II
Reported by FDA
Dec 7, 2016
Recall ID
D-0163-2017
Check your lot numberHow we source this data

Summary

Ascend Laboratories recalled Metformin Hydrochloride Tablets starting Nov 2, 2016. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-0163-2017 on Dec 7, 2016. Reason: Presence of Foreign Tablets/Capsules; report of Amlodipine Tablets found in 1000 count bottles of Metformin Hydrochloride Tablets USP. Status: Terminated.

Why it was recalled

Presence of Foreign Tablets/Capsules; report of Amlodipine Tablets found in 1000 count bottles of Metformin Hydrochloride Tablets USP

Product description

Metformin Hydrochloride Tablets, USP 500 mg, 1000 tablets, Rx Only Manufactured by: Alkem Laboratories Ltd., Mumbai - 400 013, India, Distributed by: Ascend Laboratories, LLC, Montvale, NJ NDC 67877-217-10

Lot numbers, UPCs & expiration codes

Lot 6121056, exp 5/2019

Where it was sold

AL, FL, GA, SC & TN

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0163-2017
Classification
Class II
Status
Terminated
Recall initiated
Nov 2, 2016
FDA report date
Dec 7, 2016
Quantity
1739 bottles
Recall type
Voluntary: Firm initiated
Recalling firm
Ascend Laboratories LLC

Original FDA data

Every field from FDA enforcement report D-0163-2017, exactly as published.

Show all FDA fields
City
Montvale
State
NJ
Status
Terminated
Country
United States
Event ID
75698
Address
180 Summit Ave Ste 200
Code information
Lot 6121056, exp 5/2019
Postal code
07645-1722
Report date
Dec 7, 2016
Product type
Drugs
Recall number
D-0163-2017
Classification
Class II
Recalling firm
Ascend Laboratories LLC
Product quantity
1739 bottles
Termination date
Jun 7, 2017
Reason for recall
Presence of Foreign Tablets/Capsules; report of Amlodipine Tablets found in 1000 count bottles of Metformin Hydrochloride Tablets USP
Voluntary / mandated
Voluntary: Firm initiated
Product description
Metformin Hydrochloride Tablets, USP 500 mg, 1000 tablets, Rx Only Manufactured by: Alkem Laboratories Ltd., Mumbai - 400 013, India, Distributed by: Ascend Laboratories, LLC, Montvale, NJ NDC 67877-217-10
Distribution pattern
AL, FL, GA, SC & TN
Recall initiation date
Nov 2, 2016
Initial firm notification
Letter
Center classification date
Nov 29, 2016

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0163-2017, published Dec 7, 2016. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls